Mackay Shields LLC’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-30,600
Closed -$2.01M 1418
2021
Q1
$2.01M Sell
30,600
-20,054
-40% -$1.2M 0.01% 767
2020
Q4
$2.85M Sell
50,654
-17,700
-26% -$871K 0.02% 689
2020
Q3
$3.32M Buy
68,354
+3,400
+5% +$183K 0.02% 562
2020
Q2
$3.62M Buy
64,954
+800
+1% +$46.3K 0.03% 508
2020
Q1
$3.25M Sell
64,154
-3,300
-5% -$221K 0.03% 478
2019
Q4
$5.22M Sell
67,454
-10,200
-13% -$720K 0.04% 454
2019
Q3
$4.92M Sell
77,654
-8,800
-10% -$550K 0.03% 500
2019
Q2
$5.06M Buy
86,454
+50,754
+142% +$3M 0.03% 520
2019
Q1
$2.03M Buy
+35,700
New +$1.9M 0.01% 693

Other funds holding NUVA

Mackay Shields LLC's NUVA Position: Q2 2021 in Review

Mackay Shields LLC sold out of NuVasive, Inc. (NUVA) in Q2 2021, closing a stake of 30,600 shares — an estimated $2.01M sold.

Mackay Shields LLC first reported a position in NUVA in Q1 2019 and held it in 9 quarters. The position peaked at $5.22M in Q4 2019. 259 funds tracked by Wall St. Rank hold NUVA as of Q2 2021.

  • Mackay Shields LLC reported no remaining NuVasive, Inc. position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 30,600 NuVasive, Inc. shares in Q2 2021, an estimated $2.01M.
  • Mackay Shields LLC first reported a position in NuVasive, Inc. in Q1 2019 and held it in 9 quarters.
  • Mackay Shields LLC's NuVasive, Inc. position peaked at $5.22M in Q4 2019.
  • 259 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.